The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Testosterone Undecylate (TU) Market Research Report 2025
Synopsis
Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.
The global Testosterone Undecylate (TU) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Testosterone Undecylate (TU) in Primary Hypogonadism is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Testosterone Undecylate (TU) include Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Testosterone Undecylate (TU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Undecylate (TU).
Report Scope
The Testosterone Undecylate (TU) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Undecylate (TU) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Undecylate (TU) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Testosterone Undecylate (TU) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.
The global Testosterone Undecylate (TU) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Testosterone Undecylate (TU) in Primary Hypogonadism is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Testosterone Undecylate (TU) include Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Testosterone Undecylate (TU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Undecylate (TU).
Report Scope
The Testosterone Undecylate (TU) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Testosterone Undecylate (TU) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Undecylate (TU) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Organon
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Clarus Therapeutics
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Testosterone Undecylate (TU) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2019-2030)
2.2 Testosterone Undecylate (TU) Growth Trends by Region
2.2.1 Global Testosterone Undecylate (TU) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Testosterone Undecylate (TU) Historic Market Size by Region (2019-2024)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Region (2025-2030)
2.3 Testosterone Undecylate (TU) Market Dynamics
2.3.1 Testosterone Undecylate (TU) Industry Trends
2.3.2 Testosterone Undecylate (TU) Market Drivers
2.3.3 Testosterone Undecylate (TU) Market Challenges
2.3.4 Testosterone Undecylate (TU) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Revenue
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2019-2024)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2019-2024)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2023
3.5 Testosterone Undecylate (TU) Key Players Head office and Area Served
3.6 Key Players Testosterone Undecylate (TU) Product Solution and Service
3.7 Date of Enter into Testosterone Undecylate (TU) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Testosterone Undecylate (TU) Breakdown Data by Type
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2019-2024)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2025-2030)
5 Testosterone Undecylate (TU) Breakdown Data by Application
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2019-2024)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2019-2030)
6.2 North America Testosterone Undecylate (TU) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Testosterone Undecylate (TU) Market Size by Country (2019-2024)
6.4 North America Testosterone Undecylate (TU) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2019-2030)
7.2 Europe Testosterone Undecylate (TU) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Testosterone Undecylate (TU) Market Size by Country (2019-2024)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Testosterone Undecylate (TU) Market Size (2019-2030)
8.2 Asia-Pacific Testosterone Undecylate (TU) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2019-2024)
8.4 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Testosterone Undecylate (TU) Market Size (2019-2030)
9.2 Latin America Testosterone Undecylate (TU) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Testosterone Undecylate (TU) Market Size by Country (2019-2024)
9.4 Latin America Testosterone Undecylate (TU) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Testosterone Undecylate (TU) Market Size (2019-2030)
10.2 Middle East & Africa Testosterone Undecylate (TU) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2019-2024)
10.4 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Detail
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Detail
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Detail
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Detail
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Detail
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Detail
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Detail
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Detail
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Detail
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2019-2024)
11.9.5 Zhejiang Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Testosterone Undecylate (TU) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Global Testosterone Undecylate (TU) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Testosterone Undecylate (TU) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Testosterone Undecylate (TU) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Testosterone Undecylate (TU) Market Share by Region (2019-2024)
Table 8. Global Testosterone Undecylate (TU) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Testosterone Undecylate (TU) Market Share by Region (2025-2030)
Table 10. Testosterone Undecylate (TU) Market Trends
Table 11. Testosterone Undecylate (TU) Market Drivers
Table 12. Testosterone Undecylate (TU) Market Challenges
Table 13. Testosterone Undecylate (TU) Market Restraints
Table 14. Global Testosterone Undecylate (TU) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Testosterone Undecylate (TU) Market Share by Players (2019-2024)
Table 16. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Undecylate (TU) as of 2023)
Table 17. Ranking of Global Top Testosterone Undecylate (TU) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Testosterone Undecylate (TU) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Testosterone Undecylate (TU) Product Solution and Service
Table 21. Date of Enter into Testosterone Undecylate (TU) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Testosterone Undecylate (TU) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2019-2024)
Table 25. Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2025-2030)
Table 27. Global Testosterone Undecylate (TU) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2019-2024)
Table 29. Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2025-2030)
Table 31. North America Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Testosterone Undecylate (TU) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Testosterone Undecylate (TU) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Testosterone Undecylate (TU) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Testosterone Undecylate (TU) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Testosterone Undecylate (TU) Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Testosterone Undecylate (TU) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Testosterone Undecylate (TU) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Organon Company Detail
Table 47. Organon Business Overview
Table 48. Organon Testosterone Undecylate (TU) Product
Table 49. Organon Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 50. Organon Recent Development
Table 51. Bayer AG Company Detail
Table 52. Bayer AG Business Overview
Table 53. Bayer AG Testosterone Undecylate (TU) Product
Table 54. Bayer AG Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 55. Bayer AG Recent Development
Table 56. Endo Pharmaceuticals Company Detail
Table 57. Endo Pharmaceuticals Business Overview
Table 58. Endo Pharmaceuticals Testosterone Undecylate (TU) Product
Table 59. Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 60. Endo Pharmaceuticals Recent Development
Table 61. Merck Sharp & Dohme Company Detail
Table 62. Merck Sharp & Dohme Business Overview
Table 63. Merck Sharp & Dohme Testosterone Undecylate (TU) Product
Table 64. Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 65. Merck Sharp & Dohme Recent Development
Table 66. Taro Pharmaceutical Company Detail
Table 67. Taro Pharmaceutical Business Overview
Table 68. Taro Pharmaceutical Testosterone Undecylate (TU) Product
Table 69. Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 70. Taro Pharmaceutical Recent Development
Table 71. Cipla Company Detail
Table 72. Cipla Business Overview
Table 73. Cipla Testosterone Undecylate (TU) Product
Table 74. Cipla Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 75. Cipla Recent Development
Table 76. Clarus Therapeutics Company Detail
Table 77. Clarus Therapeutics Business Overview
Table 78. Clarus Therapeutics Testosterone Undecylate (TU) Product
Table 79. Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 80. Clarus Therapeutics Recent Development
Table 81. Zhejiang Xianju Pharmaceutical Company Detail
Table 82. Zhejiang Xianju Pharmaceutical Business Overview
Table 83. Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Product
Table 84. Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 85. Zhejiang Xianju Pharmaceutical Recent Development
Table 86. Zhejiang Medicine Company Detail
Table 87. Zhejiang Medicine Business Overview
Table 88. Zhejiang Medicine Testosterone Undecylate (TU) Product
Table 89. Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2019-2024) & (US$ Million)
Table 90. Zhejiang Medicine Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Testosterone Undecylate (TU) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Testosterone Undecylate (TU) Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Global Testosterone Undecylate (TU) Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Testosterone Undecylate (TU) Market Share by Application: 2023 VS 2030
Figure 7. Primary Hypogonadism Case Studies
Figure 8. Hypogonadotropic Hypogonadism Case Studies
Figure 9. Late-Onset Hypogonadism Case Studies
Figure 10. Testosterone Undecylate (TU) Report Years Considered
Figure 11. Global Testosterone Undecylate (TU) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Testosterone Undecylate (TU) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Testosterone Undecylate (TU) Market Share by Region: 2023 VS 2030
Figure 14. Global Testosterone Undecylate (TU) Market Share by Players in 2023
Figure 15. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Undecylate (TU) as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Testosterone Undecylate (TU) Revenue in 2023
Figure 17. North America Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Testosterone Undecylate (TU) Market Share by Country (2019-2030)
Figure 19. United States Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Testosterone Undecylate (TU) Market Share by Country (2019-2030)
Figure 23. Germany Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Testosterone Undecylate (TU) Market Share by Region (2019-2030)
Figure 31. China Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Testosterone Undecylate (TU) Market Share by Country (2019-2030)
Figure 39. Mexico Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Testosterone Undecylate (TU) Market Share by Country (2019-2030)
Figure 43. Turkey Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Testosterone Undecylate (TU) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Organon Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 46. Bayer AG Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 47. Endo Pharmaceuticals Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 48. Merck Sharp & Dohme Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 49. Taro Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 50. Cipla Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 51. Clarus Therapeutics Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 52. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 53. Zhejiang Medicine Revenue Growth Rate in Testosterone Undecylate (TU) Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
